TSDRF yields 1333.33% · PFE yields 6.13%● Live data
📍 TSDRF pulled ahead of the other in Year 1
Combined, TSDRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TSDRF + PFE for your $10,000?
Tsodilo Resources Limited, an exploration stage company, acquires, explores, and develops mineral properties in the Republic of Botswana. It explores for diamond, copper, cobalt, iron, and base and precious metals. The company owns 100% interests in the Gcwihaba project comprising 5 base, precious, platinum group, and rare earth metal prospecting licenses covering an area of approximately 2,465 square kilometers located in the North-West District of Botswana; the BK16 kimberlite project and the PL 217/2016 project located in the Orapa Kimberlite Field in Botswana; and the Newdico that consists of 1 industrial mineral prospecting license covering an area of approximately 580 square kilometers located in Botswana. It also holds an interest in the gold and silver exploration license located in the Barberton area of South Africa. The company was formerly known as Trans Hex International Ltd. and changed its name to Tsodilo Resources Limited in April 2002. Tsodilo Resources Limited was incorporated in 1995 and is headquartered in Toronto, Canada.
Full TSDRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.